Analysts Call Boston Scientific (BSX) a “Forever Company” for Investors
Boston Scientific Corporation (NYSE:BSX) is one of the world’s leading medical technology innovators, recognized globally for its commitment…
Cidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company headquartered in San Diego, California, that has built its identity…
Jazz Pharmaceuticals (JAZZ)’s Latest Deal Could Make—or Break—Its Entire Future
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, and listed on the NASDAQ…
Will LYTENAVA Make History? Outlook Therapeutics (OTLK)’s Big FDA Moment Approaches
Outlook Therapeutics Inc. (NASDAQ:OTLK) is an innovative biopharmaceutical company dedicated to developing and commercializing transformative therapies for ophthalmic…
Elicio Therapeutics (ELTX): The Cancer Vaccine Revolution Changing Lives in 2025
Elicio Therapeutics, Inc. (NASDAQ:ELTX) is a clinical-stage biotechnology company pioneering the development of novel immunotherapies to combat some…
Cyclerion Therapeutics (CYCN) Poised for Massive Growth with $1.75M License Deal
Cyclerion Therapeutics Inc. (NASDAQ:CYCN) is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, dedicated to the discovery and…
Propanc Biopharma (PPCB) Raises $4M: Is This the Hidden Gem of Oncology?
Propanc Biopharma, Inc. (NASDAQ:PPCB) is an innovative biopharmaceutical company dedicated to developing breakthrough cancer therapies for patients battling…
Schizophrenia Breakthrough Alert: Minerva Neurosciences (NERV)’s Roluperidone Gains FDA Attention
Minerva Neurosciences Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker NERV, is at the…
Saudi Arabia Deal Could Catapult CEL-SCI (CVM) Into Global Biotech Spotlight
CEL-SCI Corporation (NYSE:CVM) is a pioneering biotechnology company headquartered in Vienna, Virginia, with additional operations near Baltimore, Maryland.…
Precigen (PGEN) Makes History: FDA Approves First-Ever Therapy Targeting Root Cause of RRP
Precigen Inc. (NASDAQ:PGEN) is a leading biopharmaceutical company dedicated to advancing precision medicine through innovative gene and cell…
IO Biotech (IOBT)’s Breakthrough Skin Cancer Vaccine Sparks Investor Frenzy
IO Biotech Inc. (NASDAQ:IOBT) is a clinical-stage biotechnology company dedicated to transforming cancer treatment through the development of…
Wall Street Is Watching Cadrenal Therapeutics (CVKD)’s Next Move
Cadrenal Therapeutics Inc. (NASDAQ:CVKD) is a biopharmaceutical company dedicated to developing transformative therapeutics that address the significant limitations…
Why I-Mab (IMAB) Could Be the Next Big Breakout in Global Biotech
I-Mab Sponsored ADR (NASDAQ:IMAB) is a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of…
ReShape Lifesciences (RSLS) & Vyome Merger Could Create a Healthcare Powerhouse
ReShape Lifesciences Inc. (NASDAQ:RSLS) is a premier medical device company dedicated to transforming the treatment of obesity and…
Trinity Biotech (TRIB) Could Be the Next Billion-Dollar Healthcare Innovator
Trinity Biotech plc (NASDAQ:TRIB) is a commercial-stage biotechnology company that has built its reputation on delivering innovative diagnostic…
Vor Biopharma (VOR) Could Be the Most Undervalued Biotech of the Year
Vor Biopharma Inc. (NASDAQ:VOR) is a clinical-stage cell and genome engineering company dedicated to pioneering novel treatments for…
180 Life Sciences (ATNF) Just Raised $425 Million—And It’s Not Just a Biotech Anymore
180 Life Sciences Corp. (NASDAQ:ATNF) is an emerging and unconventional player in the public markets, combining the high-stakes…
Editas Medicine (EDIT)’s $178 Million War Chest: The CRISPR Comeback Investors Can’t Ignore
Editas Medicine Inc. (NASDAQ:EDIT) is a pioneering gene editing company dedicated to translating the revolutionary potential of CRISPR/Cas12a…